Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population. Their findings were recently published in the Annals of the Rheumatic Diseases.
- Social media use linked with depression, secondary trauma during COVID-19
- Study reveals dietary fructose heightens inflammatory bowel disease
- Coming soon to a circuit near you
- Vessel noise present year-round at Cordell Bank National Marine Sanctuary
- Many ventilation systems may increase risk of COVID-19 exposure, study suggests